The AD’OCC agency, the Eurobiomed competitiveness cluster and Inserm, with the support of the Occitanie/Pyrénées-Méditerranée region, are organizing the 2nd edition of:

Biotherapies Days 

November 13 & 14, 2024 

At Montpellier’s Cité de l’Economie et des Métiers de Demain (CEMD) 

Program

Conferences, company pitches, research presentations showcasing the latest scientific discoveries, and updates on regional development projects…

Biotherapies Days is your chance to explore the thriving biotherapies and biomanufacturing ecosystem in Occitanie. The event features the Occitanie Innovation Biotherapy days and the CeBBOc key challenge. It brings together academic, private, and institutional players to foster groundbreaking collaborations.

Join us and meet key industry leaders to discover the upcoming innovations in Occitanie!

Event organization

November 13, 2024: Biotherapy Innovation Occitanie day :

 10h00 – Welcome coffee

10:30 – Introduction to Biotherapies Days / CEMD Welcome – Introduction to the Region, Ad’occ and Eurobiomed

10:45 am – Opening keynote “Biotherapies and cardiac pathologies: which biotherapy for which effect?”/ Philippe MENASCHE

11:30 – National context with France Biolead / Laurent LAFFERRERE

12:00 – BIO’OCC, presentation of new training courses, feedback on business needs / Valérie PLANAT

12:30 – Journey to 2032, towards regenerative and inclusive medicine ? / Laetitia MONTANIER

12:45 – Lunch break

2:30 pm – Pitch session for winning projects :

• Nervosave Therapeutics, Cathy BEAUMARD and Nicolas TRICAUD
• NeoVirTech, Franck GALLARDO
• INITS-SMO, Amel HADRI
• …

3:30 pm – Coffee break

4:00 pm – Techno / Platform pitches :

• OBBI Integrator / Montserrat BOSCH GRAU
• POMM platform / Houria KOLEILAT
• TOP plateform / Ibano MELI and Nathalie VERGNOLLES
• UROSPHERE / Emilie DECAUP
• Screening Fluidics / Georges GAUDRIAULT

17h15 – National and European collaboration sessions :

• Smart Immune and INITS : “Cell therapies: the multiple challenges of automated, closed production”.
• BIOCAT Cluster presented by Núria Marti

6:15pm – Roadmap 2025 for the Occitanie Innovation Biotherapy  sector and closing ceremony

6:30 pm Gala evening at Planet Ocean ! 

November 14, 2024: Cell Based Biotherapie Days 

8:30 – Welcome coffee

9:00 – Introduction to the day / Occitanie Region

9:15 – “PEPR Organ and organoid chips: a strategic contribution to personalized medicine” / Dr Anne-Marie GUE

9:55 – “Orgafert: Development of human Fallopian tube organoids as a new model for studying gametic and embryonic competence” / Eloise BRUNO

10:10 – “Cardiomyocytes derived from induced pluripotent stem cells (hIPSC) and cardiac organoid from patients: new models for the treatment of sinus dysfunction” / Nadia MEKRANE

10:40 – Speech on bioengineering / Dr Laurent MALAQUIN

11:20 – « BRIGHT : Bioprinted Retinal Interface orGanoid for Human bioTherapy : Development of 3D bioprinted human retinal interface organoids for disease modeling and drug screening » / Dr Stephane CHAVANAS et Dr Vasiliki KALATZIS

11:30 – “MiniCerveauxGlioma: Low-grade glioma and 2nd-generation mini-brain: a 3D platform for studying interactions between tumor cells and neurons, biomarker research and the development of new therapies” / Pr JP HUGNOT and Dr Sophie PAUTOT

11:40 – Presentation on biomaterials / Joelle AMEDEE-VILAMITJANA

12:20 – Lunch break

2:00 pm – “Structuring an AI collaboration in healthcare and CeBBOc” / Pr Nicolas MOLINARI

2:15 pm – Keynote “National and European landscape of MTI Cells: challenges and bioproduction obstacles” / Guillaume COSTECALDE

3:05pm: “CAAR4CURE: CAAR-MSC generation for the treatment of rheumatoid arthritis” / Carolina PRADENAS

3:20pm : “Repair: Restoration of airway mucociliary function in primary ciliary dyskinesia by cell and gene therapy using iPSC-derived bronchial epithelial progenitors” / Agathe CŒUR

3:35pm: “EXOBARRIER: Delivery of small extracellular vesicles with antiviral properties across the blood-brain barrier” / Dr Cécile MALNOU and Dr Sara SALINAS

3:45pm “EPITRANSASC: Epitranscriptomics as a biomarker of CSA aging” / Dr Xavier CONTRERAS and Dr Alexandre DAVID

3:55pm – “Round table ”Cells and EVs: Present and future” / moderated by Prof. Louis CASTEILLA and Prof. Christian JORGENSEN

4:30 pm – Closing

About the Occitanie Innovation Biotherapy sector

As Advanced Therapy Medicinal Products (ATMP) grow and regenerative medicine industrialises more, France’s health industrial sectors shift, intensifying the Occitanie Region’s efforts in launching the Occitanie Innovation Biotherapy Sector.
Occitanie Innovation Biotherapy is a collaborative strategy centred on the biotherapy and bioproduction economic sectors. It unites various regional, academic, and industrial stakeholders across the value chain, with goals to:

• Pool resources in Occitanie for faster biotherapy development and increased economic gains.
• Strengthen regional bioproduction capabilities.
• Unify stakeholders for joint projects, improving project identification and distribution.
• Boost visibility in this growing sector and elevate regional expertise in France and globally.

Occitanie Innovation Biotherapy is overseen by AD’OCC, the Region’s economic development agency, along with Eurobiomed, the competitiveness cluster, and industrial and academic representatives from the sector.

Read more : https://www.agence-adocc.com/biotherapy-innovation-occitanie/

About CeBBOc

Introduced in 2020, the “DEFIS CLES” initiative supports top-quality research on critical issues while aiming to position the Occitanie Region as a frontrunner in future sectors. Additionally, it promotes the development of new skills and future professions. The primary objective is to unite efforts, encourage synergies, and leverage skills, technical expertise, and financial resources to accomplish shared objectives.

In 2022, biotherapy research is among the 11 new “DEFIS CLES” backed by the Occitanie Region, securing a 2-million-euro regional grant for a 4-year action plan implementation.

The “DEFI CLE” CeBBOc (Cell Based Biotherapies Occitanie) aims to invigorate the regional scientific community by concentrating on cell therapies in various forms: native, amplified, modified, within 2D-3D organoid systems, or interacting with biomaterials. It seeks to bolster upstream and translational research, fostering the emergence of new sector technologies. These technologies will play a pivotal role in advancing current objectives across biomedicines, bioproduction, and organoid domains.

Read more : https://www.inserm.fr/delegation/occitanie-pyrenees/

 AD’OCC and sustainable mobility

To limit your ecological footprint, we invite you to opt for carpooling: a simple way of creating links!  

If you’d like to find or offer to carpool, we’ve created a platform just for you: 

An event organized by

Occitanie Innovation Biotherapy contacts : 

Marjorie MONLEAU – Health innovation officer – MONTPELLIER 

Bérénice CHAILLOU – Health innovation officer – TOULOUSE 

CeBBOc contact :  

Camille MALAVAL – Project manager – MONTPELLIER